343 results
424B5
LCTX
Lineage Cell Therapeutics Inc
22 Mar 24
Prospectus supplement for primary offering
4:32pm
, and is subject to a number of assumptions and limitations. Although we are responsible for all of the disclosure contained in this prospectus supplement … than one financial intermediary in the chain of ownership for an investor. We do not monitor and are not responsible for the actions of any of those
8-K
EX-99.1
0kp 29y2kd45
7 Mar 24
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:10pm
424B5
7zao2 v4qznkwkfi0eu
6 Feb 24
Prospectus supplement for primary offering
9:25am
8-K
EX-99.1
q7y3nl4aa 19
9 Nov 23
Lineage Cell Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
4:10pm